<sup>18</sup>F-FDG PET在结直肠癌中的临床应用价值

董爱生

¹⁸F-FDG PET在结直肠癌中的临床应用价值

董爱生

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 1: (12-14)

引用本文:

Citation:

¹⁸F-FDG PET在结直肠癌中的临床应用价值

董爱生

200433 上海, 第二军医大学长海医院核医学科
中图分类号: R817.4

The applications of ¹⁸F-FDG PET in colorectal carcinoma

DONG Ai-sheng

Department of Nuclear Medicine, Changhai Hospital of the Second Military Medical University, Shanghai 200433, China
CLC number: R817.4

摘要: ¹⁸F-FDG PET在结直肠癌原发、复发及转移的诊断中具有重要价值,特别是在结直肠癌的分期治疗方案的选择方面。结合CT、MRI和CEA(癌胚抗原)检测可以提高诊断的准确性。同时,¹⁸F-FDG PET在对结直肠癌的疗效监测以及评价手术效果方面也有比较重要的作用。
- 结直肠癌 /
- 正电子发射体层显像 /
- ¹⁸F-氟代脱氧葡萄糖
Abstract: PET scanning in colorectal carcinoma has a definite clinical impact on identification of primary and metastatic tumor, especially on detection, staging, and administration of the recurrent colorectal cancer and liver metastases.In addition, combined with CT, MRI, CEA and other techniques, PET can improve accuracy in diagnosis.Meanwhile, it is also important to monitor curative effect of colorectal cancer.
- positron emission tomography /
- colorectal carcinoma /
- ¹⁸F-fluoro-deoxyglucose
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Ruhlmann J, Schomburg A, Bender H, et al. Fluorode oxyglucose whole-body positron emission tomography in colorectal cancer patients studied in rourine daily practice[J].Dis Colon Rectum, 1997, 40:1195-1204.
[2]	Hung GU, Shiau YC, Tsai SC, et al. Value of ¹⁸F-FDGPET in the evaluation of recurrent colorectal cancer[J]. Anticancer Res, 2001, 21(2B):1375-1378.
[3]	Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer[J]. Ann Surg, 1998,27:319-323.
[4]	Zhuang H, Sinha P, Pourdehnad M, et al. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver[J].Nucl Med Commun, 2000, 21(9):793-798.
[5]	Fong Y, Choheb AM, Fortner JG, et al. Liver resection for colorectal metastases[J]. J Clin Oncol, 2001, 15:938-946.
[6]	Jarnagin WR, Fong Y, Ky A, et al. Liver resection for metastatic colorectal cancer:. Assessing the risk of occult irresectabale disease[J]. J Am Coll Surg, 1999, 188:33-42.
[7]	Fong Y, Saldinger PF, Akhurst T, et al. Utility of ¹⁸F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases[J]. Am J Surg, 1999, 178:282-287.
[8]	Strasberg SM, Dehdashti F, Siegel BA, et al. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma:A prospective databases study[J]. Ann Surg, 2001, 233:293-299.
[9]	Brennan MF. PET scanning in malignancy:Infant, adolescent or mature citizen[J]. Ann Surg, 2001, 233:320-321.
[10]	Park KC, Schwimmer J, Shepherd JE, et al. Decision analysis for the cost-effective management of recurrent colorectal cancer[J]. Ann Surg, 2001, 233:310-319.
[11]	Meta J, Seltzer M, Schiepers C, et al. Impact of ¹⁸F-FDG PET on managing patients with colorectal cancer:The referring physician's perspective[J]. J Nucl Med, 2001, 42:586-590.
[12]	Darius C, Desai MD, Emanuel E, et al. Positron emission tomography affects surgical management in recurrent colorectal cancer patients[J]. Ann Surg, 2003, 10:59-64.
[13]	Whiteford MH, Whitefor HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocareinoma of the colon and rectum[J].Dis Colon Rectum, 2000, 43:759-770.
[14]	Guillem JG, Puig-La CJ Jr, Akhursf T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using ¹⁸F-fluorodeoxyglucose positron emission tomography[J]. Dis Colon Rectum,2000, 43:18-24.
[15]	Bender H, Bangard N, Metten N, et al. Possible role of FDG PET the early predication of therapy outcome in liver metastases of colorectal cancer[J]. Hybridoma, 1999, 18(1):87-91.

[1]	吴湖炳 . ¹⁸F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值. 国际放射医学核医学杂志, 2005, 29(5): 205-209.
[2]	华逢春 , 管一晖 , 赵军 . ¹⁸F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用. 国际放射医学核医学杂志, 2005, 29(5): 216-219,226.
[3]	刘建军 , 黄钢 . ¹⁸F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究. 国际放射医学核医学杂志, 2005, 29(5): 213-216.
[4]	蔡莉 , 李彦生 . 氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究. 国际放射医学核医学杂志, 2005, 29(1): 10-14.
[5]	袁志斌 . 正电子肿瘤阳性显像剂¹⁸F-AMT. 国际放射医学核医学杂志, 2002, 26(5): 193-195.
[6]	陈永辉 , 李方 . 双探头符合线路¹⁸F-FDG显像在肺癌诊断中的作用. 国际放射医学核医学杂志, 2002, 26(6): 260-262,267.
[7]	温广华 . ¹⁸F-FDG PET显像在肝癌中的应用. 国际放射医学核医学杂志, 2003, 27(1): 21-24.
[8]	耿建华 , 陈英茂 . ¹⁸F-FDG图像糖代谢定量分析中的输入函数及集总常数. 国际放射医学核医学杂志, 2003, 27(6): 263-266.
[9]	袁志斌 . ¹¹C-胆碱和¹⁸F-FDG在肿瘤PET中的比较. 国际放射医学核医学杂志, 2003, 27(6): 251-254.
[10]	吴华 . 骨骼和软组织肿瘤¹⁸F-FDG PET的应用进展. 国际放射医学核医学杂志, 2003, 27(2): 49-52.